What is the emergency management for migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Management of Migraine

For emergency management of migraine, NSAIDs are the first-line therapy, followed by triptans as second-line therapy, with antiemetics as adjuncts for nausea and vomiting. 1, 2

Initial Assessment and Red Flags

  • Evaluate for red flags that may indicate secondary headache requiring different management: thunderclap headache, atypical aura, head trauma, progressive headache, fever, neck stiffness, focal neurological symptoms, or onset after age 50 1
  • Determine severity of migraine attack to guide appropriate treatment selection 2

Treatment Algorithm

First-Line Treatment (Mild to Moderate Attacks)

  • Start with NSAIDs with proven efficacy: aspirin, ibuprofen, naproxen sodium, or combination of acetaminophen plus aspirin plus caffeine 1, 2
  • Acetaminophen alone lacks evidence for efficacy in migraine treatment 1, 2
  • Administer early in the headache phase for maximum effectiveness 1

Second-Line Treatment (Moderate to Severe Attacks or Inadequate Response to NSAIDs)

  • Use triptans: oral sumatriptan (25-100 mg), rizatriptan, zolmitriptan, or subcutaneous sumatriptan 1, 2
  • Sumatriptan 50 mg offers the best balance of efficacy and tolerability, while 100 mg may provide greater efficacy but with more adverse events 3, 4
  • Consider combining triptans with fast-acting NSAIDs to prevent recurrence 1

For Attacks with Significant Nausea/Vomiting

  • Select non-oral routes of administration: subcutaneous sumatriptan or nasal spray formulations 1, 2
  • Subcutaneous sumatriptan shows the greatest and most rapid efficacy (pain relief in 59% vs 15% with placebo) but with higher adverse events 5
  • Add antiemetics such as metoclopramide or prochlorperazine to treat nausea, even if vomiting is not present 1, 2, 6

Management of Status Migrainosus (Prolonged, Severe Migraine)

  • Administer intravenous corticosteroids as the mainstay of treatment 2, 6
  • Provide IV fluids for hydration 6
  • Give antiemetics concurrently to treat nausea and improve gastric motility 6
  • Consider parenteral NSAIDs such as ketorolac for rapid onset of action 6
  • For refractory cases, consider IV magnesium sulfate 6

Important Considerations and Cautions

  • Advise early use of acute medications for maximum effectiveness 1
  • Warn patients that frequent, repeated use of acute medication risks development of medication overuse headache 1, 6
  • If a second dose is needed, wait at least 2 hours after the first dose of sumatriptan 3
  • Maximum daily dose of sumatriptan is 200 mg in a 24-hour period 3
  • Reduce maximum single dose to 50 mg in patients with mild to moderate hepatic impairment 3
  • Avoid oral ergot alkaloids, which are poorly effective and potentially toxic 1, 7
  • Limit opioid use due to questionable efficacy, adverse effects, and risk of dependency 1, 6

Follow-up Considerations

  • Evaluate for preventive therapy if patient experiences frequent attacks (generally ≥2 attacks per month) 1, 6
  • Consider prophylactic medications such as propranolol, timolol, amitriptyline, divalproex sodium, or sodium valproate 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Recommended Abortive Medications for Migraines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Defining optimal dosing for sumatriptan tablets in the acute treatment of migraine.

International journal of clinical practice. Supplement, 1999

Guideline

Treatment of Status Migrainosus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral sumatriptan for acute migraine.

The Cochrane database of systematic reviews, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.